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RESEARCH ABSTRACT 
_____________________________________________________________________________ 
 
 
It is well known that emotional stress has a negative impact on people’s health and physical, 
emotional and mental performance. Previous research has investigated the effects of stress 
on various aspects of physiology such as respiration, heart rate, heart rate variability 
(HRV), skin conductance, skin temperature and electrical activity in the brain.  Essentially, 
HRV, Electroencephalography (EEG), skin conductance and skin temperature appear to 
reflect a stress response or state of arousal.  Whilst the relationship between respiration 
rate, respiration rhythm and HRV is well documented, less is known about the relationship 
between respiration rate, EEG, skin conductance and skin temperature, whilst HRV is 
maximum (when there is resonance between HRV and respiration i.e. in phase with one 
another). 
  
This research project aims to investigate the impact that one session of slow paced 
breathing has on EEG, heart rate variability (HRV), skin conductance and skin temperature. 
Twenty male participants were randomly assigned to either a control or intervention 
group.  Physiological data were recorded for the intervention and control group during one 
breathing session, over a short initial baseline (B1), a main session of 12 minutes, and a 
final baseline (B2).  The only difference between the control and intervention groups was 
that during the main session, the intervention group practiced slow paced breathing (at 6 
breaths per minute), while the control group breathed spontaneously. Wavelet 
transformation was used to analyse EEG data while Fourier transformation was used to 
analyse HRV.    
  
The study shows that slow-paced breathing significantly increases the low frequency and 
total power of the HRV but does not change the high frequency power of HRV. 
Furthermore, skin temperature significantly increased for the control group from B1 to 
Main, and was significantly higher for the control group when compared to the intervention 
group during the main session. There were no significant skin temperature changes 
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v 
between sessions for the intervention group. Skin conductance increased significantly from 
Main to B2 for the control group. No significant changes were found between sessions for 
the intervention group and between groups. EEG theta power at Cz decreased significantly 
from Main to B2 for the control group only, while theta power decreased at F4 from Main 
to B2 for both groups. Lastly, beta power at Cz decreased from B1 to B2 for the control 
group only. 
  
This significant effect that slow-paced breathing has on HRV suggests the hypothesis that 
with frequent practice, basal HRV would increase, and with it, potential benefits such as a 
reduction in anxiety and improved performance in specific tasks. Slow-paced breathing 
biofeedback thus shows promise as a simple, cheap, measurable and effective method to 
reduce the impact of stress on some physiological signals, suggesting a direction for future 
research. 
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CHAPTER 1: INTRODUCTION  
1.1 Problem statement 
 
The interplay between respiration rate, heart rate variability (HRV), brain activity, skin 
conductance and skin temperature is an intriguing subject within physiological studies. It 
is well documented [1] [2] that breathing has a direct impact on heart rate through the 
mechanism of respiratory sinus arrhythmia (RSA), where RSA is the heart rate variability 
in synchrony with respiration [3]. HRV has also been described as an index of autonomic 
function correlating with longevity [4], and a possible marker for stress and relaxation due 
to being partially influenced by both the sympathetic and parasympathetic nervous system 
[5]. HRV biofeedback is a process whereby a participant deliberately increases HRV 
through matching respiration rate and rhythm typically guided by equipment [6]. An 
increase in HRV is considered a sign of good health and reflects the cardiovascular systems 
ability to adapt to external and internal demands [7-10]. 
 
Skin conductance and skin temperature are further markers for stress and relaxation. Skin 
conductance is a term used to describe the electrical characteristics of the skin. Both 
psychological and physiological arousal influences the sympathetic branch of the 
autonomic nervous system, which in turn controls sweat glands [11]. Skin conductance 
increases with an increase in psychological and physiological arousal [12] [13] or stress 
response [14-16]. Skin temperature is negatively correlated with stress response. During 
stress, blood flow moves from the skin and body’s extremities towards the heart and muscle 
tissues. The decrease in blood flow in fingers causes a decrease in skin temperature during 
an emotional arousal or a stress effect, while an increase in blood flow and skin temperature 
is caused during relaxation, and is therefore considered an indicator of stress or relaxation 
[17-20]. 
 
The power spectrum of spontaneous electroencephalography (EEG) offers a useful 
instrument for the assessment of cortical arousal [21]. The waking state is mostly 
characterised by power in the alpha (8-12Hz) and beta (13-30Hz) ranges in healthy 
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humans. A dominance of alpha waves indicates comparatively low activation and relaxed 
awareness without concentration [22]. An increase in beta activity reflects an increase in 
cortical activity [22], [23].   
 
In summary, HRV, EEG, skin conductance and skin temperature appear to reflect a stress 
response or state of arousal.  Whilst the relationship between respiration rate, respiration 
rhythm and HRV (and therefore potentially the sympathetic and parasympathetic nervous 
systems) is well documented, less is known about the relationship between respiration rate, 
EEG, skin conductance and skin temperature, whilst HRV is maximum (when there is 
resonance between HRV and respiration i.e. in phase with one another). 
 
1.2 Aim and objectives 
 
The aim of this research project is to investigate HRV, skin conductance and 
electroencephalography (EEG) patterns in response to breathing techniques.  This aim will 
be met through the following objectives:  
 
- To replicate existing research to determine the impacts of slow paced breathing on 
EEG and various aspects of physiology; 
- To investigate the impact of slow paced breathing on stress and relaxation as 
inferred by HRV, skin temperature, skin conductance and EEG; 
- To investigate the relationship between respiration rates, HRV, skin temperature, 
skin conductance and brain state as inferred by EEG [24, p. 66]; and 
- To use advanced signal processing techniques such as Wavelet transforms to 
evaluate EEG. 
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1.3 Hypothesis 
 
To achieve the aim and objectives of this study, the following hypotheses have been set 
out:  
- Hypothesis 1:  
H1: Slow paced breathing initiates resonance in the baroreflex system, and 
therefore increases heart rate variability. 
H0: Slow paced breathing does not initiate resonance in the baroreflex system, and 
therefore does not increase heart rate variability. 
 
- Hypothesis 2:  
H1: Slow paced breathing increases relaxation and therefore increases efferent 
vagal flow represented by increases high frequency HRV. 
H0: Slow paced breathing does not increase relaxation and efferent vagal flow, and 
therefore high frequency HRV stays constant or decreases. 
 
- Hypothesis 3: 
H1: Slow paced breathing increases relaxation, which results in decreased 
peripheral blood vessel constriction and higher peripheral blood flow, and therefore 
increases finger temperature. 
H0: Slow paced breathing does not increase relaxation, blood vessel constriction 
and peripheral blood flow remains constant, and therefore finger temperature 
remains constant or decreases. 
 
- Hypothesis 4: 
H1: Slow paced breathing increases relaxation, which reduces the sweating 
response, and therefore decreases skin conductance. 
H0: Slow paced breathing does not increase relaxation, keeping the sweating 
response constant, and therefore skin conductance remains constant. 
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- Hypothesis 5:  
H1: Slow paced breathing increases relaxation and therefore theta and alpha power 
of EEG measurement increase, while beta power decreases. 
H0: Slow paced breathing does not increase relaxation and therefore theta and 
alpha power of EEG measurement remain constant or decrease, while beta power 
remains constant or increases. 
 
1.4 Project outline 
 
This research project is divided into seven chapters.  The above chapter presents an 
introduction to the project with a brief overview of HRV, EEG and the impacts of stress 
on these, giving context to the project.  The aim of the project is presented with the 
hypotheses that are used to test the aim.  The second chapter presents a review of literature 
on HRV, HRV biofeedback and EEG.  Chapter 3 focuses on a literature review on the 
techniques used to measure and analyse HRV and EEG.  Chapter 4 outlines the 
methodology followed to test the above hypotheses based on the existing literature.  
Chapter 5 presents the results produced following the described methodology which is 
followed by a discussion and interpretation of these results in Chapter 6.  Research 
limitations and recommendations for future research are also provided.  Finally, Chapter 7 
highlights the main conclusions drawn and implications of this research. 
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CHAPTER 2: BACKGROUND AND PREVIOUS 
RESEARCH TO HRV, SKIN CONDUCTANCE, SKIN 
TEMPERATURE AND EEG 
 
2.1 Introduction  
 
This chapter presents an introduction and literature review on the physiological concepts 
of this research.  First, the concepts and mechanisms of respiration, heart rate and heart rate 
variability (HRV) is investigated in depth, as well as how HRV relates to stress and anxiety. 
Second, HRV biofeedback is discussed in terms of it being an intervention to change HRV. 
Third, the concept of electroencephalography (EEG) is introduced and also investigates its 
relationship with stress and anxiety. 
  
In general, this chapter investigates the above concepts and their relation to one another. 
Previous research on the influence of stress and anxiety on the heart and brain, as well as 
mechanisms to measure HRV, skin temperature, skin conductance and EEG are discussed, 
which form the basis of the methodology followed in this research. The word physiology 
generally refers to the study of life or biological systems, however, in this dissertation it 
will be used specifically to refer to respiration, heart, HRV, skin temperature, and skin 
conductance.  
 
2.2 Physiology background 
2.2.1 Respiration 
 
Respiration is the process of moving air in and out of the lungs with the main function to 
facilitate gas exchange of i.e. deliver sufficient amounts of oxygen and remove excess 
carbon dioxide from body tissue [25]. The neuronal circuits responsible for respiration are 
located in the medulla oblongata and the dorsolateral pons. During inspiration, pulmonary 
stretch receptors are activated sending afferent flow via the vagus nerve to the nucleus 
tractus solitaries (NTS). The NTS in turn inhibits the medullary respiratory centre 
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inhibiting inspiration with reduced efferent flow via the phrenic and intercostal nerves [26]. 
With the exception of rapid breathing, expiration occurs when intercostal muscles are 
relaxed. Central and peripheral chemoreceptors also monitor blood chemistry and respond 
to changes in pH and carbon dioxide levels, stimulating the respiratory centre, in turn 
altering rate and depth of respiration [26].  
 
2.2.2 Heart rate  
 
Heart rate refers to the frequency of complete cardiac cycles and is determined by the firing 
of the sinoatrial (SA) node in the right atrium. The SA node initiates an electrical impulse 
at the beginning of each heart beat while the atrioventricular (AV) node spreads the 
electrical signal from the SA node through the ventricles of the heart [3]. This is controlled 
and modulated from the cardiovascular centre in the medulla oblongata via efferent 
sympathetic and parasympathetic flow to the heart [27]. The cardiovascular centre receives 
information from four main receptor groups: pressure receptors in the heart; 
chemoreceptors in the heart; thermoreceptors in muscles and stretch receptors in muscles. 
The received information is then processed and heart rate is altered via the autonomic 
nervous system (ANS) as required [28].  
 
Respiratory and cardiovascular rhythms are regulated synergistically to ensure optimum 
respiratory gas exchange with respiratory sinus arrhythmia being a classical example of 
cardiorespiratory coupling [26]. 
 
2.2.3  Heart rate variability 
 
Heart rate variability (HRV) is defined as the natural variations in heart rate [29], [30] and 
reflects the ability of the cardiac system to cope with situational stress demands [7]. The 
clinical implications of HRV was first acknowledged in 1965, when [31] observed changes 
in interbeat intervals preceding fetal death. The clinical importance of HRV has since 
become widely recognised as low basal HRV has been associated with mortality following 
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Myocardial Infarction [29], hypertension [32], depressive symptoms [33], anxiety 
symptoms [34], disorder [35], panic disorder [36] and post-traumatic stress 
disorder  (PTSD) [37]. Higher basal HRV has been found after successful treatment for 
depression using psychotherapy and anti-depressants [38], [39]. Thayer et al [40] found 
evidence of a relationship between higher resting basal HRV and improved performance 
on tasks that use executive functions.  
 
Heart rate is regulated by both the sympathetic and parasympathetic branches of the ANS, 
and therefore HRV can be considered a useful marker of stress and relaxation [5]. An 
increase in HRV is considered a sign of good health and reflects the cardiovascular systems 
ability to adapt to external and internal demands [7-10]. 
 
HRV is a dynamic process of bidirectional communication between the central nervous 
system and the cardiovascular system [40-42], that is particularly influenced by the ANS 
and central autonomic network (CAN) [7], [43]. There is interconnection in almost all 
structures of the CAN, with bi-directional communication occurring between the brain and 
body [44]. Stress signals are therefore sent from the body to the brain and vice versa. 
 
Elghozi et al. [1] classifies HRV into seven types depending on the speed and mechanism 
that affects the oscillation. From slowest to fastest: age related; seasonal changes; daily 
rhythms; hourly rhythms; minute changes of between 0.5 to 5 minute periods (very low 
frequency (VLF)); medium waves (also referred to as low-frequency (LF)) with periods of 
between 7 to 15 seconds; and high frequency (HF) waves with periods of approximately 2 
to 5 seconds. The frequency bands for VLF are <0.04Hz; LF is between 0.04-0.15Hz; and 
HF 0.15-0.4Hz [29]. Due to the nature and recording length of this research project, only 
VLF, LF, and HF oscillations fall into relevant time scales. VLF is also excluded from the 
analysis as there is much debate whether any physiological process causes fluctuations to 
this frequency band [29]. Changes in HRV in the LF and HF bands are clearly influenced 
by the activity of the ANS [1]. 
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2.2.4 Low and high frequency heart rate variability 
 
Low frequency HRV oscillations are typically generated by resonance in the baroreflex 
system [45-50]. Baroreceptors sense changes in blood pressure, which in turn, send afferent 
information in combination with information from higher centres that combine at the NTS 
[51]. An increase in blood pressure triggers an inhibition of sympathetic outflow from the 
vasomotor centre to the vasculature, reducing vasomotor tone and blood pressure [52-54]. 
Vagal flow to the heart is simultaneously increased, decreasing heart rate, and therefore 
increasing HRV [55] [56]. The time delay between one blood pressure cycle to the next 
causes oscillations that occur at approximately 0.1 Hz [46], [57]. This resonant blood 
pressure oscillation is known as the Mayer wave and primarily caused by the baroreflex 
action [46], [57].  
 
Respiratory sinus arrhythmia (RSA) is the natural variation in heart rate largely modulated 
by the inhalation, exhalation, amplitude and frequency of respiration [1], [2]. RSA is also 
known as HF HRV, as it is synchronous with respiration [58], with a normal period in 
resting adults between 2 – 5 seconds, and hence a power spectral peak usually observed 
around the 0.25Hz band. One exception to RSA influencing HF HRV is during paced 
breathing, where slower breath rates could influence LF HRV [59]. Resonance between 
respiration and baroreflex oscillations occur at a respiration frequency of around 0.1 Hz, 
or approximately 4.5 to 6.5 breaths per minute [60] [61] [45] [62] [63] [64]. RSA and 
therefore HRV is maximal at resonant frequency [60]. 
 
A respiration rate of 6 breaths per minute (0.1 Hz) results in a HRV spectral peak at 0.1 Hz 
and therefore resonance [65] between respiration rate, HRV and blood pressure wave (with 
Mayer wave at 180 degrees out of phase) [61]. Peak HRV occurs at this resonant frequency, 
which differs between 4.5 to 6.5 breaths per minute, depending on the individual [66].  
 
HF HRV oscillations are regulated by efferent vagal flow [67-70]. Cyclical vagal discharge 
from the medulla is another generator of RSA [69] [71] [67] [72] and therefore contributes 
to both LF and HF HRV oscillations depending on respiration frequency. RSA increases 
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as cardiac vagal activity increases [73] [74] and decreases as vagal activity decreases [69] 
[73] [74] [50]. HF HRV power is thought to reflect cardiac parasympathetic activity [73] 
[75] [70] [76] [50] and RSA [77] when breathing is in this frequency range. LF HRV power 
was initially thought to represent sympathetic activity only [77-79], although subsequently, 
LF HRV is thought to be directly regulated by the parasympathetic nervous system (PSNS) 
[70] [49] [76] [67] [72] [68], and indirectly regulated by the sympathetic nervous system 
[49] [76] [72] [69].  
 
Central oscillators in the cardiovascular and respiratory centres contribute to both LF HRV 
oscillations [69] [77] [80] [81] as well as HF HRV oscillations [77] [82].  
 
In summary, the control and regulation of HRV is a complex system that depends on both 
peripheral and central factors [45] [57] [47]. 
2.3 HRV and depression, emotion and meditation  
 
Low basal HRV has been linked to symptoms of depression [83] [84] [85] [86] and reduced 
baroreflex sensitivity [86], possibly due to a continuous state of sympathetic arousal, 
decreased parasympathetic activity and a dulled sympathetic response to stressors [87]. 
Geisler et al [88] showed that basal HF HRV was positively correlated with subjective 
feelings of well-being. High resting state HRV has been associated with overall physical 
health [89], emotional resilience and stress vulnerability [40]. 
 
HRV patterns are not only reflective of emotional state, but are also thought to influence 
emotional experience and processing [30]. This is due to the neurological connection and 
influence from the heart to subcortical regions of the brain (such as the amygdala, thalamus 
and hypothalamus) involved in emotional processing [90], [91]. Previous studies have 
demonstrated that activity in the amygdala is synchronised with the cardiac cycle [90], 
[91]. 
 
It is interesting to note the influence of meditative and relaxation practices on respiration 
and thus heart rate.  For example, Lehrer et al [92] showed that respiration slowed during 
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Zen meditation and, as expected, RSA tracked breathing rate even at low breath rates.  It 
has also been observed, that chanting of the Pali mantra and the recital of the catholic rosary 
are both recited at 6 breaths per minute and elicit an increased baroreflex sensitivity [93]. 
 
Researchers should however, be cautious when interpreting HRV recordings as to not 
attribute changes in HF HRV and LF HRV to differences in breathing rate and RSA [94]. 
 
2.4  HRV biofeedback 
 
The definition of biofeedback has seen numerous unofficial definitions since 1971 [95], 
creating confusion among practitioners and patients, alike. In 2007, a task force was 
commissioned by the Association for Applied Psychophysiology and Biofeedback, the 
Biofeedback Certification Institute of America and the International Society for 
Neurofeedback and Research to develop an official and professional definition for 
biofeedback [6]. In 2008, this process was completed with a final definition approved by 
these institutions, as below: 
 
“Biofeedback is a process that enables an individual to learn how to change physiological 
activity for the purposes of improving health and performance. Precise instruments 
measure physiological activity such as brainwaves, heart function, breathing, muscle 
activity and skin temperature. These instruments rapidly and accurately ‘‘feed back’’ 
information to the user. The presentation of this information – often in conjunction with 
changes in thinking, emotions, and behaviour – supports desired physiological changes. 
Over time, these changes can endure without continued use of an instrument.” [6, p. 90] 
 
HRV biofeedback is performed by either matching breathing rate to a breathing pacer set 
to a specified rate [66], [41]; or by matching breathing to the individuals increase and 
decrease in heart rate, therefore maximising the chances of achieving resonant frequency 
and highest possible HRV power [96]. In both cases, breathing at a rate of between 4.5-6.5 
breaths per minute is practised, as this is where there is a maximum increase in HRV due 
to resonance. 
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Karavidas et al [97] suggests that HRV biofeedback stimulates the vagus nerve during 
practice sessions as well as in between sessions, while Lehrer et al [10] suggests that HRV 
biofeedback produces acute and chronic increases in total HRV power.  LF HRV increases 
recorded during HRV biofeedback sessions are thought to reflect resonance between 
baroreflex gain and respiratory sinus arrhythmia as well as an increase in vagus nerve 
activity [10] [61] .  
 
Numerous studies show that HRV biofeedback may be effective in reducing symptoms 
relating to depression, anxiety and optimal performance [97-101] and is discussed in 
greater detail in the following sections. 
 
2.4.1.1 HRV biofeedback mechanisms of effect 
 
Gevirtz [102] suggests HRV biofeedback training derives its many benefits from two main 
possible mechanisms. The first mechanism is a restoration of autonomic balance due to the 
improved response of disorders such as asthma [103] [104], functional gastrointestinal 
disorders [105], fibromyalgia [106] [107], hypertension [61] [108] and chronic muscle pain 
[109], using HRV biofeedback training.  The second suggested mechanism is the impact 
of vagal afferent stimulation on central effects [102].  
 
Vagal nerve stimulation, a technique using an implanted electrical device to stimulate the 
vagal afferent pathways, has been used in several studies [110-113] to successfully treat 
depressive symptoms. These techniques show promise, even though they have not been 
used in large, randomised and controlled studies. Various authors [114] [115] [9] suggest 
that certain breathing methods, which in turn stimulates sub-diaphragmatic vagal afferent 
signals, impact these same afferent pathways possibly causing an impact on central effects, 
and therefore, on depressive and anxiety symptoms. The theory for these central effects is 
supported by studies investigating the effects of interoception (the ability to sense the 
physiological condition of the body), heartbeat detection and slow paced breathing on the 
brain using heart evoked potentials techniques [116-118]. 
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Due to a combination of pharmacological and neuroimaging studies, as well as a neural 
basis. Thayer et al [40] [119] proposes that “HRV may serve as a peripheral index of the 
integrity of CNS networks that support goal directed behaviour”. They suggest their 
findings support the theory of an association between higher basal HRV and improved 
performance on tasks that use executive function. Lane et al [120] and Ahs et al [121] 
found positive correlations between HRV and cerebral blood flow in the medial prefrontal 
cortex and right supra genual anterior cingulate cortex and other cerebral areas responsible 
for emotion processing. 
 
The connection between the brain and the body is extremely complex, with the above 
section offering some descriptions of the possible mechanisms in which HRV biofeedback 
seems to alter stress and anxiety. 
 
2.4.1.2 HRV biofeedback and disease and emotion 
 
In patients with fibromyalgia, HRV biofeedback has been associated with a decrease pain 
and depression, increase overall functioning [106] and improve asthma severity [122]. 
 
It has been shown that six sessions of HRV biofeedback, over a two week period, was 
linked with a decrease in anxiety in patients with moderate to severe depression [99], and 
one brief session of HRV biofeedback was correlated with a decrease in heart rate and 
anxiety, when compared to passive relaxation techniques [123]. Karavidas et al [97] 
showed a significant improvement in the Hamilton depression scale after session four of 
HRV biofeedback and an increase in LF HRV. Nineteen individuals showed significantly 
reduced insomnia, PTSD symptoms and reduced substance craving for individuals with 
PTSD [101].  
 
HRV biofeedback has also been associated in decreasing alcohol and drug cravings [41]; 
food cravings and eating and weight concerns in individuals frequently experiencing lack 
of control over eating [124]. 
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2.4.1.3 HRV biofeedback and performance 
 
HRV biofeedback is suggested to improve the performance of physical activities, such as 
dance performance [125] and golf performance, due to a decrease in anxiety [126].  
 
Prinsloo et al [127] demonstrated that a single session of biofeedback training was 
associated with improved reaction times, while making fewer mistakes on a modified 
stroop test when compared to a control group. The intervention participants were also more 
relaxed and awake. 
 
There is some controversy on the efficacy of biofeedback. During a triple-blind randomised 
study, Raaijmakers et al [128] found no differences in treatment effect and no correlation 
between HRV and cognitive variables between two groups.  
 
2.5 Stress and physiology 
2.5.1 Skin conductance biofeedback 
 
Skin conductance (SC), electrodermal response (EDR), and electrodermal activity (EDA) 
are a few of the commonly used terms used to describe the electrical characteristics of the 
skin. Psychological or physiological arousal, a dimension of an emotional response, 
influences the sympathetic branch of the ANS that in turn controls sweat glands [11], [129]. 
As arousal [12], [13] or stress response [14-16] increase, so does SC, and is therefore 
considered to be an indicator of an emotional and sympathetic response [130], [131]. 
 
2.5.2 Skin temperature biofeedback 
 
During stress, blood flow moves from the skin and body’s extremities towards the heart 
and muscle tissues. The decrease in blood flow in fingers causes a decrease in skin 
temperature during an emotional arousal or a stress effect, while an increase in blood flow 
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and skin temperature is caused during relaxation, and is therefore considered an indicator 
of stress or relaxation [17-20] Lin et al. [132] demonstrated that a percentage increase in 
finger temperature was most sensitive to indexing stress and depression, followed by a 
percentage increase in skin conductance, heart rate, and respiration rate. 
 
2.6 Electroencephalography (EEG) 
 
EEG equipment measures the electrical potential between different scalp positions and a 
reference point, produced by the summation of postsynaptic electrical field of similarly 
aligned neuronal dendrites and other intra cranial electrical activity [133] [22]. Anywhere 
between one and more than 300 electrodes [24, p. 68] can be used during a recording; 
however, often the 10-20 international system is used that has 19 active electrodes that 
cover different areas of the scalp, with an additional electrode that provides a reference. 
The reference electrode is often placed over the mastoid bone behind the ear or on the 
earlobe. The captured data/signal is a waveform that has an electrical potential at a specific 
frequency measured as a voltage over time. Each electrode is brought into high 
conductivity (below 5kΏ) with the scalp by gently rubbing the scalp through a hole in the 
back of the electrode with a stick to remove excess dirt, followed by inserting conducting 
gel between the electrode and scalp. The voltage from each electrode is fed into a 
differential amplifier, to enhance the difference between each active electrode and the 
reference electrode. This electrode voltage is then digitised and saved for artefacting and 
analysis at a later stage.  
 
Evaluations of the brain using EEG have mixed reviews, with advantages being its 
simplicity, relatively low cost, ease of use and temporal resolution. EEG has been widely 
accepted and used to determine brain state as inferred by frequency analysis [24, p. 66], 
however some critics suggest that it gives mere insight into the working of the brain [134].   
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2.6.1  Cerebral cortex, EEG frequency and state of 
consciousness 
 
The human brain can be separated into three main divisions: 1) the brainstem that relays 
sensory and motor signals between the spinal cord and higher brain centres; 2) the 
cerebellum that is responsible for aspects of cognition and fine control of muscle 
movement; and 3) the largest part of the brain, the cerebrum, with the cerebral cortex as 
the outer layer [133]. The thickness of the cerebral cortex varies between 2 – 5 mm with 
cortical neurons densely covered and strongly interconnected. Each area of the cortex has 
a different function to fulfil, with the prefrontal cortex being largely responsible for 
executive functions [22].  
 
A person’s state of consciousness is reflected by the frequency and shape/form of the EEG 
signal. The states are grouped into delta, theta, alpha, sensorimotor rhythm (SMR), beta 
and gamma. Delta waves are usually considered to be between 1-4Hz; theta between 4 – 8 
Hz; alpha between 8 – 12 Hz (however alpha is often sub-divided into alpha 1: 8 – 10 Hz 
and alpha 2: 10 – 12 Hz); SMR between 12 – 15 Hz, however, only when measured over 
the sensorimotor cortex; beta 1 between 13 – 20 Hz, beta 2 between 20 – 30 Hz; and 
gamma 30 – 50 Hz [23], [22]. 
 
Each wave is characterised by various states of consciousness and functions.  Delta waves 
are usually associated with deep sleep [23], while theta waves have been linked to 
creativity, meditation, access to unconscious material, drowsiness [135], tasks requiring 
memory [136], [137], mental imagery, enhanced internalised attention and monitoring of 
internal processes [23], [138].  Alpha waves often take a sinusoidal morphology and 
traditionally indicate cortical idling or relaxed awareness without concentration [22, p. 71]. 
This understanding is correct for simple sensory-motor tasks [23], however does not hold 
true for all circumstances. Alpha 1 appears to indicate internalised attention, expectancy, 
and alertness, while alpha 2 appears to indicate activity of brain modules used in task 
performance [139].  Beta waves are associated with focussed executive processing, active 
thinking, attention, problem solving and outward focus, and is considered as the waking 
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state of the brain [22], [23].  Various other EEG waves exist, however these are not used 
in this research and are therefore beyond the scope of further discussion. 
 
2.6.2  Link between EEG, PET, MRI and HRV 
 
During Zen meditation, Takahashi et al [139] found an increase in theta and alpha power 
in frontal areas suggesting enhanced internalised attention; and an increase in HF HRV and 
decrease in LF HRV suggesting increased parasympathetic activity and decreased 
sympathetic activity. A negative correlation between normalised LF HRV power and 
frontal alpha power was also found. 
 
Using positron emission tomography (PET), Lane et al [120] showed that there was a 
positive correlation between HF HRV and emotion specific regional cerebral blood flow 
(rRCB) in the medial prefrontal cortex, the thalamus, the caudate nucleus and the left mid-
insula. It was concluded that, as brain activity increases, the braking action on the heart 
increases. Gianaros et al [140] also used PET to correlate HF HRV to ventral AAC during 
a memory task, and found that an increase in task difficulty decreases HF HRV, indicating 
decreased cardiac parasympathetic activity. During an fMRI study, Critchley et al [141] 
showed a correlation between HRV and dorsal anterior cingulate cortex (ACC) during 
mental and physical stress.  
 
The above pharmacological and neuroimaging studies [120] suggest a link between 
prefrontal neural function and HRV. Thayer et al [40] found evidence of a relationship 
between higher resting basal HRV and improved performance on tasks that use executive 
functions.  
 
2.6.3  EEG and meditation 
 
Meditation can be defined as a practice regime for the cultivation of well-being, relaxation 
and emotional balance [142]. Lutz et al [142] categorise the majority of meditation 
  
________________________________________________________________________ 
  
17 
techniques into two styles: focused attention meditation that entails the voluntary focus on 
a particular object and open monitoring meditation that involves non-reactive observing of 
current experience. A third category, automatic self-transcending, is added by [23], where 
techniques are used to transcend the practitioner’s own activity. Slow paced breathing 
could be considered closest to focused attention meditation. 
 
Focused attention meditation techniques such as, loving-kindness-compassion [143], 
Qigong [144], and Zen [145], have a positive correlation with an increase in EEG gamma 
power (30-50Hz) and EEG beta 2 power (20-30Hz). Open-monitoring techniques such as 
Vipassana [146], Zen [147], Sahaja Yoga [148], have a positive correlation with an 
increase theta; while Automatic Self-Transcending techniques such as Transcendental 
Meditation [149], [150], have a positive correlation with an increase in frontal alpha power 
and coherence. 
 
Yu et al [151] evaluated a form of Zen meditation, where the practitioner used focussed 
attention on their abdomen to control their breathing at a rate of roughly 3-4 breaths per 
minute. They found an increase in alpha band and a decrease in theta band during and after 
focused attention on abdominal breathing. EEG results correlated with blood (peripheral) 
serotonin (5-HT) levels. While these results suggest that the activation in the prefrontal 
cortex and/or peripheral 5-HT levels may be responsible for EEG changes, this cannot be 
concluded definitively as there was no control group involved. It is also noted that 
peripheral 5-HT levels are entirely different from 5-HT neuro transmitter levels in the brain 
(central). 
 
Wang et al [152] used the Fast Fourier Transform (FFT) method to analyse long term Zen 
meditators versus a control group with no meditation experience. It was found that the long 
term meditators have a slower mean frequency, greater theta and alpha power at rest, when 
compared with novices.  
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2.6.4  EEG and breathing 
 
Prinsloo et al [127] and Park et al [153] demonstrated that slow paced abdominal breathing 
is correlated with a brain state that is calm and relaxed while awake and alert. Prinsloo’s 
research showed an increase in relative theta power and in theta/beta ratio, with a decrease 
in relative beta power, while Park showed that paced breathing was correlated with an 
increase in low frequency alpha and decreased theta. In a separate study, Prinsloo et al 
[154] showed that HRV biofeedback, which is a method that causes participants to breathe 
at a rate of between 4.5 to 6 breaths per minute, was positively correlated with participants’ 
cognitive performance during a modified stroop test, with both speed and accuracy. 
Fumoto et al [155] demonstrated that abdominal breathing at 3-4 breaths per minute was 
positively correlated with vigour-activity with a tendency of anxiety reduction.  
 
Various research efforts have focused on the effects of breathing on the EEG, with each 
applying different breathing techniques and methodologies. These differences are likely to 
account for some of the inconsistencies in results. A summary of this research follows in 
the section below. 
 
Fumoto et al [155] compared EEG information of 20 minutes of rest to 20 minutes of 
rhythmic breathing (eyes open and closed on different days) at Cz, C3, C4, Fz, and Pz 
at 3- 4 breaths per minute. High and low alpha increased significantly more during paced 
breathing then autonomic breathing at all locations. Participants had an increased feeling 
of vigor-activity, with a reduction in anxiety during and after paced breathing, which 
correlates to the increase in high alpha [156]. 
 
Park et al [153] compared EEG information of 15 minutes of rest to 15 minutes of paced 
breathing at (eyes closed condition) at F3, F4, T3, T4, P3, and P4. In general, an increase 
in low and high alpha was found with a local decrease in theta, indicating internal and 
external awareness and alertness.   
 
  
________________________________________________________________________ 
  
19 
Other studies found only marginal increase in alpha brain frequency [157] and [158], or a 
decrease in beta brain frequency [127]. The incongruences in results might be attributed to 
differences in methodologies, such as duration of slow paced breathing (only three minutes 
for [158]), the number and placement of EEG electrodes on the skull and methodology to 
calculate the power in different frequency bands.  
2.6.5  EEG and stress and anxiety 
 
There are numerous studies that examine the effect that stress and anxiety have on EEG 
signals. According to a study by Knyazev et al [159], state and trait anxiety scores were 
negatively correlated to relative delta power across all sites. 
  
An increase in frontal midline theta reflects relief from anxiety [160-162], mental 
concentration [163] and correlates with HF HRV from relaxation training [129]. An 
increase in theta, rather than alpha, is often seen as a reliable marker for relaxation [164]. 
During a breathing intervention designed to reduce stress in participants, relative theta 
power and theta/beta ratios increased while relative beta power decreased during the 
intervention [127].  A decrease in alpha reflects relaxation [161], while an increase in 
relative alpha has been shown to correlate to state and trait anxiety scores [159].  In other 
research, beta power increased with an increase in stress [165], [166], and paying 
attention  [166] while decreasing in response to relaxation stimuli [167], [168], [127].  
Total absolute power has been shown to increase with anxiety [165], [169]. 
2.7 Summary  
 
The above chapter firstly presents an introduction and literature review on the concepts and 
mechanisms relating to respiration, heart rate, HRV, biofeedback, skin conductance, skin 
temperature and EEG. Furthermore, previous research relating to the relationship between 
these concepts and breathing, stress, relaxation, meditation and emotion are investigated.    
 
In summary, both positive emotion and breathing at a rate of 6 breaths per minute has the 
ability to increase HRV. In turn, resonance may be induced between respiration, HRV and 
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blood pressure at the body’s natural resonant frequency of approximately 0.1 Hz. This 
resonance potentially impacts brain state and may have the benefit of reducing stress and 
increasing performance.  Chapter 3 provides information on the technical aspects of 
measuring and analysing the concepts introduced in this chapter. 
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CHAPTER 3: BACKGROUND AND PREVIOUS 
RESEARCH ON SIGNAL PROCESSING 
3.1 Introduction 
 
In Chapter 2, various physiological concepts are introduced and their known relationships 
to each other are investigated.  This chapter presents an introduction and literature review 
on the technical aspects of this research, namely signal processing. The analysis of HRV, 
breathing, skin conductance, skin temperature and EEG is described.  The practical aspects 
of EEG recordings and EEG signal processing techniques are also discussed. 
 
3.2 HRV analysis 
 
Heartbeat, and therefore the interbeat interval (IBI) time necessary to calculate HRV, can 
be measured by either an electrocardiogram (ECG) or blood volume pulse (BVP) sensor, 
also known as a photoplethysmographic (PPG) sensor. An ECG sensor measures the 
electrical activity of the heart that provides a more precise signal with fewer movement 
artifacts when compared to a BVP sensor, however it is not without its drawbacks. An ECG 
sensor is more cumbersome, obtrusive and more time consuming to apply [170] than a 
BVP sensor. The BVP sensor measures changes in blood volume in the tissue, capillaries 
and arteries by shining infrared light through the tissues, and then measuring the amount 
of light that is reflected. The amount of reflected light measured by the BVP sensor is 
proportional to the volume of blood in the tissue [170]. Using a BVP sensor has an 
advantage in that the shape of the signal reflects cardiovascular variables such as blood 
pressure; while the amplitude indicates an individual’s response to physical and emotional 
stressors, and vasodilation (therefore peripheral temperature) [171] . Speckenbach et 
al  [171] demonstrated that BVP sensors for biofeedback training were highly reliable.   
 
HRV is commonly evaluated using time, frequency domain, rhythm pattern analysis and 
non-linear techniques, with each technique reflecting different neural regulatory 
changes [29]. Only frequency domain analysis is evaluated in this research study. 
Frequency domain analysis can be performed using either parametric or non-parametric 
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methods, with both methods providing similar results [29]. Non-parametric methods such 
as the FFT have advantages such as ease of implementation and high processing speeds; 
while parametric methods provide smoother spectral components and an accurate 
estimation of power spectral density with a small number of samples. 
 
Heartmath [30] is more concerned with the heart rhythm pattern, rather than the heart rate 
or change in heart rate. An increase in HRV coherence is defined as a large increase in 
power band around 0.1 Hz (low frequency) and a decrease in the 0.0033 - 0.04 Hz (very 
low frequency) and 0.15 - 0.4 Hz (high frequency) bands [172]. Interbeat-intervals are 
firstly measured from the heartbeat (either acquired from an electrocardiogram (ECG) or 
BVP sensor), storing them every 500 ms, and then calculating coherence with the following 
technique for the latest 64 seconds of data. The frequency where the maximum power peak 
in the low frequency range (0.04 - 0.26 Hz) is found and the integral in a 0.03 Hz window 
centred on this peak frequency is calculated (see Figure 3.1). The total power is calculated 
by taking the integral of the entire spectrum and the coherence ratio is calculated using the 
following equation: 
 
𝐶𝑜ℎ𝑒𝑟𝑒𝑛𝑐𝑒 𝑟𝑎𝑡𝑖𝑜 = (
𝑝𝑒𝑎𝑘 𝑝𝑜𝑤𝑒𝑟
𝑡𝑜𝑡𝑎𝑙 𝑝𝑜𝑤𝑒𝑟−𝑝𝑒𝑎𝑘 𝑝𝑜𝑤𝑒𝑟
)
2
               (3.1) 
 
 
Figure 3.1: Illustration by Heartmath demonstrating how coherence ratio is calculated [30]. 
 
The approach that this research applies for the HRV calculation is based on the work from 
the task force of The European Society of Cardiology and The North American Society of 
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Pacing and Electrophysiology [29]. FFT transforms provide information on how much 
power or heart rate variance is distributed as a function of frequency [1]. Spectral power 
density of the HRV is calculated in each fixed frequency band (VLF <0.04 Hz; LF 
between 0.04 – 0.15 Hz; and HF between 0.15 – 0.4 Hz), over a 64 second moving average 
and stored every 62.5 ms. These values are averaged over a whole session to obtain the 
final value. 
 
The units for LF HRV and HF HRV are in ms2, and these can be normalised using the 
following formulae [29]: 
 
𝐿𝐹 𝑛𝑜𝑟𝑚 =  
𝐿𝐹 𝑃𝑜𝑤𝑒𝑟
𝑇𝑜𝑡𝑎𝑙 𝑃𝑜𝑤𝑒𝑟−𝑉𝐿𝐹 𝑃𝑜𝑤𝑒𝑟
×100                 (3.2) 
 
𝐻𝐹 𝑛𝑜𝑟𝑚 =  
𝐻𝐹 𝑃𝑜𝑤𝑒𝑟
𝑇𝑜𝑡𝑎𝑙 𝑃𝑜𝑤𝑒𝑟−𝑉𝐿𝐹 𝑃𝑜𝑤𝑒𝑟
×100                    (3.3) 
 
 
HRV movement artifacts are manually removed using BioGraph infinity version 6.0.2 
before any calculations are processed. 
 
3.3 Respiration analysis 
 
As far as the author is aware, no previous studies have assessed breathing quality by 
evaluating the respiration percentage power in the LF band (0.04 - 0.15 Hz). One 
representation for the percentage respiration power in the LF band is the quality 
(smoothness and rhythm) of a participant’s breathing.  
 
This is evaluated in the same way as calculating HRV LF norm [29], except calculating the 
power spectral density of respiration inhalation and exhalation (from a strain gauge) instead 
of from HRV signals. The Fourier transform of the participants’ respiration was 
determined, and the percentage power in the LF range over the total range was calculated. 
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3.4 Equipment and Electroencephalography (EEG) 
 
Electroencephalography (EEG) is the process and technology of measuring and recording 
the electrical signals of the brain, in order to analyse a person’s brain state [22]. 
 
Surface EEG is considered non-invasive [24], quiet, relatively tolerant of patient 
movements, does not require exposure to high intensity magnetic fields, and hardware costs 
are significantly less than other methods to study brain function.  
 
Some disadvantages of EEG are listed below: 
 
 EEG is most sensitive to post-synaptic potentials that are generated from within the 
cerebral cortex (the outer crust of the cortex), on the crests of the gyri adjoining the 
skull. Neural activity deeper within the cortex, within the sulci, or that produce 
currents at a tangent to the skull have less contribution to the EEG signal. 
 EEG has a relatively poor spatial sensitivity when compared with other methods of 
studying brain function. 
 As some neuron electric potentials cancel each other out, it is mathematically 
impossible to reconstruct an intracranial current source from given EEG recordings. 
This is known as the inverse problem, however, much work has been done to 
generate good estimates. 
 EEG takes a large amount of time to connect electrodes to the scalp and establish 
good, low impedance connections. 
 
3.4.1  Alternative commonly used equipment 
 
Some of the most common equipment used for assessing brain anatomy and physiological 
function are briefly discussed below. 
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Cerebrospinal fluid, brain tissue, blood and bone have different densities to one other. CAT 
scan usually takes 9 or 12 slices of the brain using X-ray technology, and show brain 
anatomy and possible haemorrhage. 
 
Magnetic resonance imaging (MRI) and functional magnetic resonance imaging (fMRI) 
can be used for imaging brain anatomy and brain physiological function respectively. They 
use three magnetic fields to distort the behaviour of protons, and record the amount of time 
it takes for the protons to recover. This information is then used to create an image of the 
anatomy of the brain. As the MRI scan uses magnetic fields, individuals with pacemakers 
and metal within the body not connected to hard tissue cannot be subjected to a MRI scan. 
fMRI uses the knowledge that cerebral blood flow and blood oxygenation are accompanied 
by neuronal activity [22, p. 65], which infers different levels of activity in different brain 
areas.  
 
Like MRI, PET examines the metabolic activity of the brain. Its main advantages are that 
it allows doctors and researchers to first measure an amount of a specific compound used 
by different areas of the brain, and second provides absolute levels of brain metabolism 
due to blood flow, oxygen use, and glucose metabolism. 
 
3.4.2  EEG equipment 
3.4.2.1 EEG electrodes 
 
EEG electrodes are made from a variety of different metals, the most common being silver-
silver chloride (Ag/AgCl) due to its low dc offset variability and its ability to quickly 
establish and maintain stable electrochemical potentials against biological tissue. Ag/AgCl 
electrodes are also considered to be non-polarisable, that is, the potential between the scalp, 
conducting solution, and metal does not change significantly when current passes through 
the electrode. Other metals used are tin, stainless steel, gold plated silver, and pure gold or 
silver. Using electrodes made from different metal for the EEG and reference electrode can 
result in altered EEG recordings, as each type of metal has different electrochemical 
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properties. It is therefore important to use the same type of electrodes for all scalp 
locations [173, p. 119]. 
    
Electrodes can either be passive (the scalp potential is only amplified at the EEG amplifier) 
or active (the scalp potential is pre-amplified using electronic circuitry at the electrode). 
Due to high impedance matching properties between the scalp and electrode amplifier’s 
input, active electrodes are inherently more stable over a broader range of scalp impedances 
and have a larger tolerance to impedance differences between different scalp electrodes. 
They also have a better cable noise immunity between electrode and amplifier due to the 
electrode amplifier’s low output impedance [133, p. 29]. Should passive electrodes be used, 
scalp to electrode impedances should be kept below 5 kΩ to ensure good stability and noise 
immunity. Similarity between the different electrodes to scalp impedances is also 
important. Achieving good EEG recordings is largely due to proper scalp preparation 
(slight mechanical abrasion to remove dead skin cells), conducting gel application and 
impedance checking. 
 
3.4.2.2 EEG amplifier 
 
The amplifier circuitry amplifies the potential difference between each electrode and the 
reference electrode (typically around 30 – 50 µV) using differential amplifiers. This 
analogue voltage is then converted into a digital number for storage and future 
processing [174].  
 
3.4.3  EEG protocols and montage 
3.4.3.1 Electrode placement 
 
In the 1950’s, the first standards in EEG were defined and among them was an electrode 
placement system known as the international 10-20 system, named as each electrode [175] 
is either 10% or 20% to the adjacent electrode of the total distance between the nasion and 
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inion [175]. Since then, alternative systems have been developed that allow for a greater 
number of electrodes to be used if required [133, p. 31].  
 
When using the 10-20 system, electrodes placed over the left and right hemisphere are 
labelled with odd and even numbers respectively, while electrodes placed over the midline 
are labelled a - z. The uppercase letter is an abbreviation for the skull bones that underlie 
the cerebral cortex, namely the: frontal, parietal, temporal and occipital lobes [24]. For 
example, P4 is off centre towards the right hemisphere over the Parietal lobe, as illustrated 
in Figure 3.2. 
 
 
Figure 3.2: Demonstration of electrode placement using the 10-20 International placement system [173]. 
 
3.4.3.2 Montage 
 
EEG machines use differential amplifiers, therefore the output recorded potential is the 
difference in voltage between the measuring electrode and a reference. The reference could 
be another electrode or the average of a group of electrodes. Montage is the rule which 
states the relationship between the measuring electrode and reference.  
 
  
________________________________________________________________________ 
  
28 
Often when recording digital EEG, the reference electrode is connected to either one or 
two earlobes (mastoids, chin, or tip of nose can also be used) in the linked ear montage. 
The montage and filter setting can then be changed when the EEG is reviewed [173]. 
 
Ideally, the reference is electrically neutral and stable; however, as all sites on the head are 
at least slightly electrically active, there is no ideal and therefore the recorded voltage is 
influenced by a non-ideal reference.  The typical montage attempts to deal with this by 
averaging the potentials over all the electrodes and using this as a reference for each 
channel. Another common montage is the local average montage, in which a unique 
reference is calculated for each measuring electrode by averaging the potential of a number 
of electrodes in the vicinity of the measuring electrode. The bipolar or sequential montage 
is calculated by finding the difference between two measuring electrodes located on the 
scalp. For example, F4/C4 or F7/T3 [176]. 
 
 
Figure 3.3: Montages (a) linked ear, (b) common average, and (c) local average. Adapted from [173]. 
 
3.4.4  Artifacts 
 
EEG artifacts are unwanted electrical potentials of non-brain origins that are merged with 
the electrical potentials of the brain during EEG recording and prevent accurate analysis of 
brain activity [177].  
 
(a) (b) (c) 
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An artifacts origin is either non-physiological (faulty electrodes or electrode pop, or noise 
from external sources such as AC lines) or physiological (eye or tongue movement, teeth 
grinding, swallowing, breathing, ECG, sweat, and electromyography/muscle 
movement) [177], [178]. Figures 3.4 – 3.7 demonstrate the impact of different artifact on 
EEG signals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Red circles indicate electrode pop. Reproduced with permission from [177]. 
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Figure 3.5: Red arrows indicate 60Hz AC line artifact. Reproduced with permission from [177]. 
 
 
Figure 3.6: Red arrows indicate eye movement artifact. Reproduced with permission from [177]. 
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Figure 3.7: Red arrows indicate teeth grinding artifact. Reproduced with permission from [177]. 
 
Several techniques have been developed for artifact removal, with the majority removing 
the entire segment of contaminated data. The most common of these methods are: simple 
amplitude threshold, min-max threshold, gradient criterion, spectral distribution, standard 
deviation and joint probability [133], [179]. The rejection of all epochs contaminated by 
artifact can result in a large amount of data loss, therefore methods based on filtering, 
Principal Component Analysis, regression analysis and Independent Component Analysis 
(ICA) have been developed for correcting the artifacts rather than deletion [177], [180].  
 
ICA is a processing method that decomposes a multichannel signal into statistically 
independent components [178], [133], and is based on the assumption that artifacts and 
brain activities are generated by independent processes [179]. There is a possibility that 
part of the EEG signal may also be lost when removing the artifact component [178].   
 
Delorme et al [181], [182] developed a program (EEGLAB) for semi-automated artifact 
rejection. It includes routines to identify artifacts such as improbable data, extreme values, 
abnormal trends, abnormal spectra and routines to identify and remove independent 
components.  
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3.5 EEG signal processing techniques 
3.5.1  About the EEG signal 
 
The human brain is not a fully stochastic or deterministic system otherwise it would not be 
able to create anything new or learn and repeat thoughts and tasks [183]. The EEG signal 
is generated by both nonlinear and linear neuronal dynamics [184-188]. The brain could 
therefore be considered a complex nonlinear system and one of its outputs, the EEG signal, 
a nonlinear, nonstationary (or quasi-stationary up to 0.25 seconds), and noisy 
signal [135], [183] that contains useful information regarding brain state [189], [190].  
  
3.5.2  Linear analysis of non-stationary signals 
 
Signals that are statistically stationary are easy to characterise in either the frequency or 
time domain. Often signals are analysed in the frequency domain using linear transforms 
such as the Discrete Fourier Transform (DFT), or the Discrete Cosine Transform. As EEG 
signals are non-stationary (amplitude or frequency varies over time), other techniques such 
as the Short Time Fourier Transform (STFT) and the Wavelet Transform have been used 
to analyses signals in the time frequency domain [135]. 
 
3.5.3  Short time Fourier transform (STFT) 
 
The STFT can be used to find the distribution of energy in the time-frequency space by 
applying the STFT to extracted successive short pieces of signal using a window 
function [135]. 
 
𝑋(𝑛, 𝜔) = ∑ 𝜒(𝜏)𝓌(𝑛 − 𝜏)𝑒−𝑗𝜔𝑡∞𝜏=−∞                (3.5) 
   
Where 𝜒(𝜏) is the signal to be transformed and 𝓌(𝑡) is the window function [135, p. 56]. 
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There is always a trade-off between time or frequency resolution when using the STFT. 
From the equation above, it can be seen that the shorter the duration of the time window, 
the better the temporal resolution and poorer the frequency resolution. As the time window 
increases, the frequency resolution increases and temporal resolution decreases [190]. 
 
3.5.4  Wavelet analysis  
 
Wavelet analysis refers to a type of multiresolution analysis that uses wavelets and wavelet 
packets to decompose nonstationary signals providing exceptional joint time-frequency 
resolution [191]. 
 
Wavelet transforms have better accuracy then FFT, however a larger ambiguity in signal 
decomposition. In addition, wavelets have a faster computational speed compared to the 
STFT [192], and have been shown to offer better spectral characteristics and detect brain 
diseases more effectively than FFT [193] 
 
3.5.4.1 Background to Wavelet Transform 
 
Wavelets are oscillating amplitude functions of time with requirements to satisfy certain 
conditions: a wavelet   must have a zero mean amplitude, with small lower frequency 
energy compared to its higher frequency energy and finite energy over its time 
course [191]. A mother wavelet is the type of wavelet chosen to perform the wavelet 
transformation, while a wavelet family is created by a process of scaling and translation of 
the mother wavelet in order to create an infinite number of wavelets in the family. Scaling 
with parameter 𝑠 and translating with 𝑢 results as equation 3.6. 
 
Ψ𝑢,𝑠(𝑡) =
1
√𝑠
Ψ (
𝑡−𝑢
𝑠
)                       (3.6)
       
The term translation refers to the location of the wavelet in time, while scaling or dilation 
refers to the process of stretching or compressing a wavelet. Stretching a wavelet increases 
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the scale, making it less localised in time and shifting its spectrum to lower frequencies 
with a higher magnitude. The converse holds true for compressing a wavelet. Wavelets 
therefore obey the Heisenberg Uncertainty principle due to the trade-offs between time and 
frequency localisation as the wavelet is stretched or compressed. Wavelet analysis has an 
advantage over the STFT in that it can give good time resolution (with poor frequency 
resolution) at high frequencies and good frequency resolution (with poor time resolution) 
at low frequencies [194].  
 
The Continuous Wavelet Transform (CWT) for a one-dimensional signal 𝑓(𝑡) can be 
calculated using (3.7), where * denotes the complex conjugate, Ψ(𝑡) is the analysing 
wavelet, 𝑠 is the scale parameter that is inversely proportional to frequency and 𝑢 is the 
translation parameter [135].  
 
𝐹(𝑢, 𝑠) =
1
√𝑠
∫ 𝑓(𝑡)
∞
−∞
Ψ∗ (
𝑡−𝑢
𝑠
) 𝑑𝑡                   (3.7) 
                              
The CWT scales and translates the mother wavelet by infinitely small steps in relation to a 
continuous signal while computing the wavelet coefficient at each step. The above equation 
shows that the wavelet transform produces an infinite set of wavelet coefficients 
𝐹(𝑢, 𝑠) when 𝑠  and 𝑢 are varied, for a given signal 𝑓(𝑡). Due to the unnecessary 
redundancy for most applications, the CWT is inefficient and time consuming to compute. 
Mallat [195] developed a much more efficient and computationally simpler wavelet 
analysis technique called the Discrete Wavelet Transform (DWT) that provides a highly 
efficient wavelet representation that can be implemented with a recursive filter system. 
 
The DWT decomposition, as seen in figure 3.8, is obtained by passing the original signal 
through successive half band low and high pass filters with an impulse response determined 
by the chosen wavelet. Due to the frequencies being halved, and according to the Nyquist 
rule, half of the samples can be eliminated by discarding every other sample (subsampling). 
This subsampling process doubles the scale of the signal, while the filtering process halves 
the amount of frequency information in the signal [196]. The filtering and subsampling 
together constitute one level of decomposition that outputs both detail and approximation 
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coefficients and can be repeated for further levels of decomposition. Each level of 
decomposition halves the time resolution (since the number of samples that characterise 
the signal is halved) and doubles the frequency resolution (since the frequency band is half 
the previous level). The coefficients represent a correlation between the original signal and 
the chosen wavelet at different scales and translation [190]. 
 
 
Figure 3.8: DWT recursive filter and decomposition scheme. 
 
An advantage of the DWT is that the original signal, or any level of decomposition, can be 
reconstructed using a filter system as per figure 3.5. The process is reversed by upsampling 
the coefficients, filtering and summing them together. 
 
 
Figure 3.9: DWT reconstruction scheme. 
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3.5.4.2 Wavelet packets 
 
A wavelet packet is a group of signals found at the end of each decomposition level derived 
from a single mother wavelet. The difference between conventional DWT and wavelet 
packet decomposition, is that only the approximation coefficients are decomposed into 
deeper levels during the conventional method; whereas both approximation and detail 
coefficients can be decomposed for the latter method. Wavelet packet decomposition is 
especially useful when evaluating neuro electric waveforms such as EEG signals, as 
previous literature specifies distinctions in frequency bands (e.g. beta 1 and beta 2) that are 
found in deeper levels of the detail bands. Figure 3.6 demonstrates this advantage when 
evaluating EEG signals comparing the two methods using a four level decomposition tree. 
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Figure 3.10: Comparison between the standard DWT (bold line) and wavelet packet decomposition (dashed 
line). Adapted from [191]. 
 
3.5.4.3 Choosing a Wavelet 
 
The type of application and signal being analysed should determine the type of wavelet 
used. The ability of the wavelet transform to choose a wavelet with a morphology as close 
as possible to the shape of the neuroelectric events being analysed, gives a large advantage 
over traditional Fourier techniques. A wavelet can be designed to match the shape of the 
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signal of interest using a matching pursuit technique, or the direct design technique by 
matched Meyer wavelets. 
 
3.6 Summary 
 
This chapter has provided relevant background information for this study relating to the 
techniques used to measure and analyse HRV, respiration and electrical brain signals.  A 
detailed description of EEG equipment has also been included.  Furthermore, EEG signal 
processing techniques (Wavelet Transforms) are discussed in detail which forms the basis 
of the methods used to analyse the EEG data.  The study methodology is discussed in 
greater depth in Chapter 4. 
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CHAPTER 4: METHODOLOGY 
 
4.1 Introduction 
 
This chapter deals with the methods and materials used in the undertaking of this 
dissertation.  It describes the scope of research design, equipment and analyses situated 
amongst existing research strategies that were used to test the hypotheses of the project.   
 
4.2 Sampling strategy 
 
Twenty male participants from the psychology and electrical engineering department at 
Wits University were invited to volunteer for the research study through the Wits 
University psychology website. The subject information sheet and consent form (Appendix 
A and Appendix B, respectively) were placed on the Wits psychology notice website 
through which potential volunteers were able to contact the research investigator to 
volunteer. 
 
Participant exclusion criteria that was stated were as follows: previously diagnosed anxiety, 
cardiac, psychiatric or epilepsy disorders; current use of heart rate altering medications; or 
current use of stimulants or recreational drugs. Women were also excluded from this study 
as men and woman may have different EEG [197] and cortisol [198] responses to stress, 
and therefore may also have different physical responses to breathing at different rates. 
 
The following ethical guidelines were put into place for the research period: 
- The dignity and wellbeing of students was protected at all times; 
- Ethics was approved by the Wits University Human Research Ethics committee 
(Protocol number: M130611, Appendix C); 
- All participants read and signed the consent form; 
- No participant was subordinate to the researcher;  
- Recording EEG data is considered non-invasive [24]; and 
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- The research data remained confidential throughout the study and the researcher 
obtained the students’ permission to undertake the assessment. 
 
Of the volunteers that started the study, there was one dropout due to work commitments. 
The mean age of the participants was 26.8 (± 6.31) years. The participants’ ethnicity was 
divided into 10 black, 8 white and 2 coloured. Participants were randomly assigned to 
either a control or intervention group. 
 
4.3 Procedure 
4.3.1  General 
 
All participants attended two sessions. The first was an information, preparation and 
training session; while the second session that took place approximately one week later 
was the actual experiment where measurements were recorded and questionnaires filled 
out. 
 
There was no literature found on fainting due to slow paced breathing, however, some 
participants may occasionally experience slight dizziness due to breathing too deeply and 
hyperventilating [35]. Participants were advised both verbally prior to the study and in the 
patient information sheet to revert to their normal breathing pattern and abandon the study 
should dizziness occur. Participants were seated in a comfortable chair with arm rests and 
the researcher was present at all times, so that there was no foreseeable risk of injury in the 
unlikely event of fainting. 
 
Five EEG sensors, BVP, temperature, skin conductance and respiration sensors were 
connected to participants during the second session to record EEG readings and 
physiological responses of participants. 
 
A successful session was defined as one that contained small enough artifact that could be 
removed, and enough useful information extracted from the physiology and EEG signals. 
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4.3.2  First session: Training  
 
During the first session, the procedure for both the intervention and control groups was as 
follows: 
 
1. Welcoming and introduction to the venue;  
2. Reading and signing of the consent form;  
3. Reading the participant information sheet;  
4. Advice provision on what stimulants and food to abstain from for 2 hours before 
the second experiment as per the participant information sheet;  
5. Explanation of what the experiment was about, including the function of sensors 
that was to be connected in the second session;   
6. Questions and answers. 
 
The control and intervention groups had respiration and BVP sensors connected to 
familiarise the participants with the sensors and software, however, the intervention group 
was also taught pursed lipped abdominal breathing (as per the below instructions), whereas 
the control group was not. 
 
4.3.3  Second session: Experimental 
 
The actual experiment consisted of connecting all sensors to participants 
(approximately 20 min), followed by 3 recording sessions: Baseline 1 (B1), the Main 
session (M), and Baseline 2 (B2).  B1 was a 3 minute eyes open baseline recording (to 
establish participants’ regular EEG and physiology patterns) where subjects were required 
to look at a blank screen as seen in Figure 4.1. The intervention group breathed at 
approximately 6 breaths per minute (established by synchronising their breathing to a 
visual stimuli) for 12 minutes, while the control group breathed at a spontaneous rate for 
12 minutes. All participants then had another 3 minute eyes open baseline recording (B2), 
followed by removal of equipment. Participants were asked to answer a short written 
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questionnaire at the start and end of the procedure. The whole experiment took less than 1 
hour and 10 minutes.  
 
 
 
Figure 4.1: Blank screen on BioGraph Infiniti software that all participants looked at during Baseline 1 and 
2. 
  
 43 
 
Figure 4.2: Screen on BioGraph Infiniti software that participants from the intervention group looked at during the main session. Participants matched their breathing 
with that of the yellow marker which moved up and down along the grey line at a rate of 6 cycles per minute. In the top graph, the blue line represents participants’ 
inhalation and exhalation measured using a respiration belt and the pink line represents increase and decrease in heart rate. The bottom graph illustrates the 
participants’ heart beat taken measured using a BVP sensor.  The respiration rate is indicated by the figure in the top right screen. 
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Figure 4.3: Screen on BioGraph Infiniti software that participants from control group looked at during the main session. In the top graph, the blue line represents 
participants’ inhalation and exhalation measured using a respiration belt and the pink line represents increase and decrease in heart rate. The bottom graph illustrates 
the participants’ heart beat measured using a BVP sensor.  The respiration rate is indicated by the figure in the top right screen. 
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4.3.4  Instructions for pursed lipped abdominal breathing 
 
A five-minute training session with verbal instructions, modified from Lehrer et al. [96], 
was given to the intervention participants during the first session to assist them in following 
a visual breathing pacer that guided them to breathe at 6 breaths per minute. During this 
session, a respiration strain gauge belt and BVP sensor were connected to participants. 
 
The instructions provided to the intervention participants were as follows: 
 
- Place one hand on your stomach and the other on your chest, 
- Breathe into stomach and feel the hand on the stomach moving outwards during the 
in breath, and inwards during the out breath. Try to keep the hand on your chest 
still, 
- Let the rate of your in-breath and outbreath be gently guided by synchronising your 
breathing with the yellow dot on the EZ-Air program.  
 
 
Figure 4.4: EZ-Air breathing pacer. 
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4.3.5  Questionnaires 
 
Two questionnaires’ (Appendix D) were filled out by each participant at the beginning and 
end of the second session. The first two were the Smith Relaxation States Inventory 
(SRSI3) to measure various aspects of relaxation, stress, meditation and mindfulness in the 
participants’ general state at that specific point in time. Participants repeated one of the 
SRSI3 questionnaires at the end of the experiment so that a “before and after” intervention 
comparison on the effects of the intervention could be made. The second questionnaire was 
aimed at recording the participants’ subjective experiences of the experiment.   
 
The questionnaires were used to assess any major discrepancies in participants’ EEG and 
physiological measurements, and for future research. 
 
4.4 Hardware and sensor placement 
 
EEG and physiological signals were recorded using the 10 channel Flexcomp Infinity made 
by Thought Technology. Five EEG electrodes (Model: 9305M) were placed at 
international 10-20 system [175] locations FP1, FP2, F3, F4, and Cz with linked ear 
references. Another four channels were used to record respiration information, inferred 
from abdominal movement from a respiration strain gauge belt (Model: SA9311M) worn 
over the abdominal area; heart rate from a BVP sensor (Model: SA9308M) lightly clamped 
over the middle finger; skin conductance (using a small sensor in a Velcro strap wrapped 
around the ring and index finger, Model: SA9309M), and skin temperature (using a sensor 
lightly strapped to the baby finger. Model: SA9310M). All finger sensors were connected 
to the left hand of each participant. All channels data was recorded at a rate of 2048 samples 
per second. 
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4.5 Sensor technical specifications and equipment used 
 
BVP, respiration and skin temperature bandwidth were not specified by the manufacturer, 
however, the type of sensors used should be more than adequate due to the low frequency 
waveforms recorded by these sensors. 
 
EEG (Thought Technology T9305M) 
Input impedance    10GΩ in parallel with 10pF 
Signal input range   0 –200µV 
Sensitivity      <0.1µVRMS 
CMRR       >130dB 
Channel bandwidth   2Hz – 1kHz 
Accuracy      ±0.3µVRMS, ±5% of reading @10°C to 40°C 
 
BVP (Thought Technology SA9308) 
Input range Unit less quantity displayed as 0% – 100% 
Accuracy      ±5% 
 
Respiration (Thought Technology SA9311M) 
Range       30% – 65% 
 
Skin conductance (Thought Technology SA9309M) 
Input Impedance    >1012Ω in parallel with 10pF 
Operating Input Bias  ~ 1.0 to 2.0 V above sensor ground 
Signal Input Range   ± 40 mV  
Channel Bandwidth  0.05 Hz - 1 kHz 
Signal Output Range  ± 2.0 V (+ 2.8 V if used with Sensor Isolator) 
Input / Output Gain   50 
Supply Voltage    7.26 V (±0.05 V)  
Current Consumption  < 1.5 mA 
Accuracy      ±5% 
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Skin temperature (Thought Technology SA9310M) 
Temperature range   10°C - 45°C  
Accuracy      ±1.0°C between 20°C – 40°C  
 
4.6 Software 
 
All data was initially captured in Thought Technology’s BioGraph Infiniti software 
(version 6.02). The EEG data was exported to EEGLAB (version 13.4.4b) for pre-
processing, and then to MATLAB (version R2012a), where the Wavelet Transform was 
used to decompose the signal into five different frequency bands at all five locations of the 
EEG signal. Physiology data was first artifacted in the Biograph Infinity software, and then 
exported into MATLAB where further processing and averaging was implemented. 
 
EEG pre-processing consisted of reducing the sampling rate to 256 Hz, using a FIR filter 
to low pass filter the signal with an upper edge of 60 Hz, and high pass filter the signal 
with a lower edge of 1 Hz; visually and manually artifacting “one of a kind” noise activity 
from the signal, and finally using ICA to further artifact the signal from eye blinks and 
movement, and temporal muscle activity. 
 
The artifacted and averaged absolute EEG signal was normalized using the natural 
logarithmic transform (ln(𝑥)) [199-203], as well as finding the normalised relative value 
(ln(𝑥 1 − 𝑥⁄ )) as per [199-204]. In both cases, x is a dimensionless version of the value 
being transformed. 
4.7 Statistical analysis 
 
The data were analysed using IBM SPSS Statistics (version 22), with a significance level 
of p <0.05 set for the tests. The independent variable was considered to be respiration 
frequency, whilst the dependant variables were EEG, HRV, skin conductance and skin 
temperature. 
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Normality of EEG, HRV, skin conductance and skin temperature was evaluated by 
assessing skewness and kurtosis. HRV, skin conductance and skin temperature were all 
determined to be non-normally distributed. Although more normal than the absolute EEG 
data, the normalised EEG data were still found to be non-normally distributed. As such, 
non-parametric tests were used to analyse EEG and physiology data. Friedman’s analysis 
of variance for repeated measures [205] was first used to determine significant differences 
between tests for each group. The Wilcoxon matched pairs test [206] was then used to 
determine the specific differences. Due to multiple comparisons being conducted on the 
Wilcoxon matched pairs tests, a Bonferroni correction was applied that resulted in a 
significance level set at p <0.017 being set. The Mann–Whitney U test [207] was used to 
determine the differences between groups. 
 
4.8 Summary 
 
In conclusion, this chapter describes the methodology and instrumentation used in 
collecting and analysing the data for this research.  The sampling strategy and procedure 
followed are discussed.  Aspects relating to the hardware used for executing the research, 
as well as software used for data processing and analysis are also described. The results of 
the data analysis is presented in the following chapter. 
  
________________________________________________________________________ 
  
50 
CHAPTER 5: RESULTS 
5.1 Introduction and Overview 
 
This chapter presents the results of the data analysis performed following the methodology 
that was set out for the project. 
5.2 Physiology results 
 
Physiological parameters examined include respiration frequency (RF), heart rate, heart 
rate variability, skin temperature and skin conductance (results shown in Table 5.1). 
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Table 5.1: Comparison of physiological median, quartile 1 (Q1) and quartile 3 (Q3) results during the B1, 
Main and B2 sessions for the control (N=8) and intervention group (N=10). 
 
 
  
 
 
 
 
 
 
Baseline 1 Main Baseline 2
Percentiles Percentiles Percentiles
Variable Group Median 25th 75th Median 25th 75th Median 25th 75th
Respiration Int 0,23 0,17 0,28 0,12 0,11 0,13 ##,*** 0,21 0,15 0,25 +,**
frequency  (hz) Con 0,28 0,26 0,30 0,27 0,26 0,28 0,27 0,26 0,29
Resp - % power Int 11,64 2,68 38,51 89,10 84,78 92,28 ##,*** 24,44 7,76 64,00 ++,*
in LF band Con 6,62 5,80 8,61 10,09 6,89 12,09 5,42 3,09 17,07
Heart rate Int 67,39 61,20 71,90 69,76 62,92 76,79 69,35 62,41 75,93
(b/min) Con 66,57 59,47 74,15 64,10 58,59 73,97 65,00 55,95 76,77
HRV - LF band Int 214,33 135,57 473,38 1877,14 1594,87 2348,14 ##,*** 300,42 164,69 1303,69 ++
(ms
2
) Con 112,85 59,49 289,05 223,04 75,34 329,93 147,66 116,55 373,15
HRV - HF band Int 113,80 44,54 312,74 180,92 47,61 353,76 173,03 63,96 281,18
(ms
2
) Con 212,33 88,04 476,70 186,55 127,54 504,61 192,03 83,36 387,99
HRV - Total Int 681,09 278,43 1003,79 2262,52 1887,42 2697,04 ##,*** 623,01 371,65 1597,42 ++
power (ms
2
) Con 607,59 229,49 743,80 519,46 354,47 1184,02 426,34 365,52 1052,86
HRV - LF norm Int 55,15 42,85 85,92 93,00 85,83 96,25 *** 71,17 59,25 77,80 +
(%) Con 41,92 30,71 56,97 56,73 33,94 66,32 61,36 36,57 69,86
Skin temp Int 28,97 24,57 34,00 28,74 26,36 34,45 * 29,44 26,09 34,51
(deg C) Con 33,90 30,61 35,37 34,73 32,94 35,49 # 33,79 32,71 35,61
Skin temp delta Int 0,30 -0,01 1,00
(deg C) Con 0,33 -0,18 0,96Skin 
conductance Int 0,90 0,23 1,54 0,75 0,41 1,30 0,64 0,43 1,66
 (µS) Con 0,91 0,72 2,95 0,83 0,62 2,60 1,26 0,70 3,47 +Skin 
conductance Int -0,10 -0,54 0,04
delta (µS) Con -0,14 -0,43 0,00
Time effect between B1 and Main (Wilcoxon matched pairs test)
# p<0,017 CON-ST 
## p<0,01 INT-RF; INT-RLF%P; INT-HRV-LF; INT-HRV-TP 
Time effect between B1 and B2 (Wilcoxon matched pairs test)
 ^p<0,017
^  ^p<0,01
Time effect between Main and B2 (Wilcoxon matched pairs test)
+ p<0,017 INT-RF; INT-HRV-LFNorm; CON-SC 
++p<0,01 INT-RLF%P; INT-HRV-LF; INT-HRV-TP
Group effect (Mann–Whitney U test)
* p<0,05 INT B2 RLF%P vs CON B2 RLF%P; INT Main ST  vs. CON Main ST 
** p<0,01 INT B2 resp  vs. CON B2 resp; 
***p<0,001 INT Main resp  vs. CON Main resp; INT Main RespLF%P vs CON Main RespLF%P; INT Main LF-HRV 
vs CON Main LF-HRV; INT Main HRV-TP vs CON Main HRV-TP; INT Main HRV-LFN vs CON Main HRV-LFN 
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RF significantly decreased in the intervention group from B1 to Main (z= -2.8, p<0.01), 
and then significantly increased from main to B2 (z= -2.49, p<0.017), as breathing was 
altered by matching breathing to the breathing pacer (Figure 5.1). No significant 
differences were found in RF between the three sessions for the control group.  In 
comparing the control and intervention group, RF was significantly lower (z= -3.67, 
p<0.001) during Main and during B2 (z= -2.94, p<0.01) for the intervention group.  No 
other significant differences were found for RF between the control and intervention group 
(Table 5.1). 
 
Figure 5.1: Box and whisker diagram showing distribution of mean respiration frequencies (per participant) 
during the B1, Main and B2 sessions for both control and intervention groups. Mild and extreme outliers are 
represented by the O and * symbols, respectively.  
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The respiration percentage power in the LF band increased significantly (z= -2.8, p<0.01) 
from B1 to Main, and then significantly decreased from Main to B2 (z= -2.7, p<0.01) for 
the intervention group. There was a significant increase of the intervention group during 
both the Main (z= -3.67, p<0.001), and B2 (z= -2.04, p<0.05) sessions when compared to 
the control group.  
 
 
 
Figure 5.2: Box and whisker diagram showing distribution of mean respiration LF percentage power (per 
participant) during the B1, Main and B2 sessions for both control and intervention groups. Mild and extreme 
outliers are represented by the O and * symbols, respectively. 
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LF HRV power significantly increased (z= -2.8, p<0.01) from B1 to Main and then 
significantly decreased from Main to B2 (z= -2.8, p<0.01) for the intervention group 
(Figure 5.3). No significant differences were found in LF HRV power between the three 
sessions for the control group.  There was a significant increase (z= -3.59, p<0.001) for the 
intervention group when compared to the control group during the Main session.  
Furthermore, there were no significant differences for either group for HF HRV (Table 
5.1). 
 
 
 
Figure 5.3: Box and whisker diagram showing distribution of mean heart rate variability power in the LF 
band (per participant) during the B1, Main and B2 sessions for both control and intervention groups. Mild 
and extreme outliers are represented by the O and * symbols, respectively. 
 
  
________________________________________________________________________ 
  
55 
HRV total power increased significantly (z= -2.8, p<0.01) from B1 to Main, and then 
decreased significantly (z= -2.8, p<0.01) from Main to B2 for the intervention group, 
showing no carry over effect (Figure 5.4). No significant differences were found in HRV 
total power between the three sessions for the control group.  There was a significant 
increase (z= -2.94, p<0.001) in total power of the intervention group when compared to the 
control group during the Main session (Table 5.1). 
 
 
 
Figure 5.4: Box and whisker diagram showing distribution of mean heart rate variability total power (per 
participant) during the B1, Main and B2 sessions for both control and intervention groups. Mild and extreme 
outliers are represented by the O and * symbols, respectively. 
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HRV LF norm for the intervention group (Figure 5.5 and Table 5.1) was significantly 
higher (z= -3.4, p<0.001,) in comparison to the control group during the main session. 
 
 
 
Figure 5.5: Box and whisker diagram showing distribution of mean normalised low frequency heart rate 
variability power (per participant) during the B1, Main and B2 sessions for both control and intervention 
groups. Mild and extreme outliers are represented by the O and * symbols, respectively. 
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Skin temperature significantly increased (z= -2.42, p<0.017) for the control group from B1 
to Main (Figure 5.6 and Table 5.1). There were no significant skin temperature changes 
between sessions for the intervention group.  The skin temperature of the control group 
was significantly higher (z= -2.04, p<0.05) when compared to the intervention group 
during the Main session.  
 
 
Figure 5.6: Box and whisker diagram showing distribution of mean finger skin temperature (per participant) 
during the B1, Main and B2 sessions for both control and intervention groups. Mild and extreme outliers are 
represented by the O and * symbols, respectively. 
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Skin temperature delta was defined as the change in the average skin temperature of the 
first 1.5 minutes from the average skin temperature of the last 1.5 minutes during the Main 
session. No significant differences in skin temperature delta was found between groups 
(Table 5.1). 
 
 
Figure 5.7: Box and whisker diagram showing distribution of mean change in finger skin temperature (per 
participant) between the first and last 1.5 minutes of the main session for both control and intervention groups. 
Mild and extreme outliers are represented by the O and * symbols, respectively. 
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Skin conductance increased significantly (z= -1.71, p<0.017) from Main to B2 for the 
control group. No significant changes were found between sessions for the intervention 
group and between groups (Table 5.1). 
 
 
Figure 5.8: Box and whisker diagram showing distribution of mean skin conductance (per participant) during 
the B1, Main and B2 sessions for both control and intervention groups. Mild and extreme outliers are 
represented by the O and * symbols, respectively. 
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Skin conductance delta was defined as the change from the average skin conductance of 
the first 1.5 minutes to the average skin conductance of the last 1.5 minutes during the 
Main session. There were no significant differences in skin temperature delta between the 
sessions for the control and intervention group, as well as between groups. 
 
 
Figure 5.9: Box and whisker diagram showing distribution of mean change in skin conductance (per 
participant) between the first and last 1.5 minutes of the main session for both control and intervention groups. 
Mild and extreme outliers are represented by the O and * symbols, respectively. 
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5.3 EEG results – natural logarithm 
 
EEG bands examined include theta, alpha and beta (results shown in Table 5.2).  Two 
methods of normalising data exist: natural logarithm and relative, and it was decided to 
evaluate the EEG results using both methods.  This section shows those EEG results using 
natural logarithm.  Ten participants were used in the intervention group and nine 
participants were used in the control group; however, one participant’s EEG recording in 
the control group data was unusable due to noise.    
 
Table 5.2: EEG median, quartile 1 (Q1) and quartile 3 (Q3) results (normalised using natural log) during the 
B1, Main and B2 sessions for the control (N=8) and intervention group (N=10). 
 
 
Baseline 1 Main Baseline 2
Percentiles Percentiles Percentiles
Site Group Median 25th 75th Median 25th 75th Median 25th 75th
Theta Cz Int 1,115 0,998 1,222 1,134 0,961 1,234 1,044 0,924 1,188
Power Cz Con 1,051 0,868 1,093 1,018 0,862 1,044 0,950 0,753 0,986 +
(4-8Hz) F3 Int 0,945 0,872 1,143 0,934 0,824 1,186 0,939 0,815 1,109
F3 Con 0,880 0,839 1,079 0,838 0,785 0,976 0,837 0,627 0,920
F4 Int 0,909 0,725 1,010 0,928 0,691 1,037 0,906 0,735 1,012
F4 Con 0,821 0,675 0,945 0,793 0,656 0,886 0,714 0,527 0,855 +
Alpha Cz Int 1,246 1,127 1,382 1,265 1,067 1,353 1,249 1,123 1,495
Power Cz Con 1,066 0,989 1,189 1,043 0,963 1,123 0,993 0,816 1,091
(8-16Hz) F3 Int 1,126 0,977 1,291 1,137 0,963 1,317 1,175 0,999 1,379
F3 Con 1,014 0,931 1,087 0,899 0,822 1,096 0,856 0,739 1,086
F4 Int 1,019 0,866 1,212 1,083 0,892 1,242 1,126 0,911 1,266
F4 Con 0,877 0,826 1,035 0,837 0,682 1,076 0,797 0,600 1,021
Beta Cz Int 1,314 1,021 1,555 1,351 1,014 1,523 1,410 1,022 1,663
Power Cz Con 1,011 0,829 1,193 0,980 0,755 1,176 0,948 0,709 1,130 ^
(16-32Hz) F3 Int 1,095 0,876 1,466 1,130 0,960 1,431 1,123 0,984 1,581
F3 Con 0,898 0,754 1,192 0,878 0,663 1,140 0,890 0,609 1,169
F4 Int 1,016 0,817 1,358 1,093 0,839 1,346 1,072 0,908 1,502
F4 Con 0,802 0,671 1,112 0,822 0,571 1,085 0,875 0,488 1,100
Time effect between B1 and Main (Wilcoxon matched pairs test)
# p<0,017 None
## p<0,01 None
Time effect between B1 and B2 (Wilcoxon matched pairs test)
 ^p<0,017  Con-Beta_Cz
^  ^p<0,01 None
Time effect between Main and B2 (Wilcoxon matched pairs test)
+ p<0,017 Con-Theta_Cz; Con-Theta_F4 
++p<0,01 None
Group effect (Mann–Whitney U test)
* p<0,05 None
** p<0,01 None
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In terms of theta power, significant differences were only found at Cz and F4 locations 
(Table 5.2).  Theta power at Cz decreased significantly from Main to B2 (z= -2.521, 
p<0.017) for the control group (Figure 5.10) only. Theta power at F4 decreased 
significantly from the Main to B2 (z= -2.521, p<0.017) for the control group (Figure 5.11), 
with no other significant results being found between sessions and between groups. 
 
 
 
Figure 5.10: Box and whisker diagram showing distribution mean theta power at Cz (per participant) during 
the B1, Main and B2 sessions for both control and intervention groups. Mild and extreme outliers are 
represented by the O and * symbols, respectively. 
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Figure 5.11: Box and whisker diagram showing distribution of mean theta power at F4 (per participant) 
during the B1, Main and B2 sessions for both control and intervention groups. Mild and extreme outliers are 
represented by the O and * symbols, respectively. 
 
 
No significant results were found between sessions and between groups for Alpha power 
(Table 5.2).     
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In terms of beta power, significant differences were found only at the Cz location (Table 
5.2), where beta power decreased significantly from B1 to B2 at Cz (z= -1.54, p<0.017) 
for the control group (see Figure 15.12). 
 
 
Figure 5.12: Box and whisker diagram showing distribution of mean beta power at Cz (per participant) during 
the B1, Main and B2 sessions for both control and intervention groups. Mild and extreme outliers are 
represented by the O and * symbols, respectively. 
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5.4 EEG results – Relative 
 
This section shows those EEG results using the relative method.  Ten participants were 
used in the intervention group and nine participants were used in the control group; 
however, one participant’s EEG recording in the control group data was unusable due to 
noise.    
Table 5.3: EEG median, quartile 1 (Q1) and quartile 3 (Q3) results (normalised using relative method) during 
the B1, Main and B2 sessions for the control (N=8) and intervention group (N=10). 
 
 
 
 
Baseline 1 Main Baseline 2
Percentiles Percentiles Percentiles
Site Group Median 25th 75th Median 25th 75th Median 25th 75th
Theta Cz Int 0,189 0,173 0,207 0,184 0,172 0,218 0,181 0,149 0,202
Power Cz Con 0,193 0,156 0,204 0,192 0,171 0,210 0,191 0,160 0,199
(4-8Hz) F3 Int 0,181 0,170 0,204 0,180 0,162 0,206 0,174 0,148 0,200
F3 Con 0,180 0,142 0,202 0,181 0,156 0,197 0,172 0,142 0,197
F4 Int 0,180 0,167 0,203 0,181 0,158 0,207 0,178 0,144 0,196 +
F4 Con 0,180 0,137 0,195 0,180 0,150 0,198 0,168 0,143 0,189 +
Alpha Cz Int 0,216 0,196 0,233 0,217 0,193 0,227 0,216 0,205 0,222
Power Cz Con 0,204 0,191 0,227 0,205 0,188 0,226 0,202 0,192 0,226
(8-16Hz) F3 Int 0,211 0,195 0,227 0,214 0,193 0,227 0,208 0,195 0,221
F3 Con 0,195 0,165 0,224 0,193 0,179 0,219 0,195 0,169 0,211
F4 Int 0,211 0,194 0,224 0,212 0,194 0,227 0,204 0,198 0,219
F4 Con 0,193 0,170 0,220 0,191 0,180 0,213 0,190 0,173 0,217
Beta Cz Int 0,230 0,186 0,248 0,225 0,186 0,254 0,246 0,190 0,264
Power Cz Con 0,196 0,168 0,203 0,191 0,180 0,201 0,191 0,185 0,214
(16-32Hz) F3 Int 0,204 0,183 0,248 0,211 0,185 0,234 0,221 0,185 0,250
F3 Con 0,187 0,157 0,194 0,183 0,169 0,193 0,183 0,170 0,212
F4 Int 0,208 0,183 0,248 0,213 0,187 0,228 0,223 0,183 0,241
F4 Con 0,183 0,160 0,203 0,178 0,172 0,199 0,182 0,173 0,215
Time effect between B1 and Main (Wilcoxon matched pairs test)
# p<0,017 None
## p<0,01 None
Time effect between B1 and B2 (Wilcoxon matched pairs test)
 ^p<0,017 None
^  ^p<0,01 None
Time effect between Main and B2 (Wilcoxon matched pairs test)
+ p<0,017 Int-Th_F4; Con-Th_F4; 
++p<0,01 None
Group effect (Mann–Whitney U test)
* p<0,05 None
** p<0,01 None
  
________________________________________________________________________ 
  
66 
In terms of theta power, a significant difference was found only at the F4 locations 
(Table  5.3), where relative theta power at F4 decreased significantly from the Main to B2 
(z= -2.38, p<0.017) for the control group and deceased significantly (z= -2.38, p<0.017) 
intervention group (Figure 5.13). Furthermore, no other significant results being found 
between sessions and between groups at other locations (Table 5.3). 
 
 
 
Figure 5.13: Box and whisker diagram showing distribution of mean relative theta power at F4 (per 
participant) during the B1, Main and B2 sessions for both control and intervention groups. Mild and extreme 
outliers are represented by the O and * symbols, respectively. 
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5.5 Summary 
 
Chapter 5 presents the results following the methodology discussed in the previous 
chapters. Important findings and analyses have been highlighted and are discussed in the 
following chapter.  Chapter 6 provides a detailed discussion based on the findings of the 
results presented in this chapter. The chapter then revisits the hypotheses tested to reach 
the objectives of the study, as well as highlights some key limitations of this research 
project and where scope for future research should be directed. 
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CHAPTER 6: DISCUSSION  
 
6.1 Introduction 
 
This chapter presents a discussion on the results presented in Chapter 5.  Firstly, the impacts 
of respiration on HRV, skin conductance, skin temperature and EEG, and the implications 
thereof are discussed.  Thereafter, the hypotheses are revisited based on the results.  Finally, 
a discussion is provided on the limitations of this research and where future research should 
be focused. 
 
6.2 Respiration and HRV 
 
As expected, the intervention group was able to follow the breathing pacer and alter 
breathing frequency to around 0.1Hz (6 breathes per minute) during the main session. Even 
though the intervention groups breathing frequency increased from main to B2, it stayed 
below B1’s frequency, and was significantly lower than the control group’s B2 result. This 
indicates that slow paced breathing has an extended impact on the participants’ breathing 
patterns. 
 
Some researchers [77-79] suggest that LF HRV power represents sympathetic activity 
only, while others [69], [208] a combination of sympathetic and vagal influences, making 
the LF/HF ratio a representation of the sympo/vagal balance [29].  Furthermore, it is well 
know that respiration (known as RSA) has a modulating impact on HRV [1], [2] and 
influences LF HRV during slow paced breathing, as they are in the same frequency band 
[59]. Therefore, LF HRV does not accurately reflect sympathetic or vagal activity for this 
research and will not be evaluated further. 
  
Vagal activity [29] and parasympathetic activity [77] [73] [75] are considered as the main 
contributors towards the HF component of HRV, with an increase indicating a more 
relaxed state, and a decrease indicating a more stressful state [209] [210]. There was no 
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significant difference in either group for HF HRV indicating that one session of slow paced 
breathing was not enough to alter HF HRV such that it becomes a marker for relaxation. 
 
Low basal HRV is linked with hypertension [32], depressive symptoms [33], anxiety 
symptoms [211], [34] and disorder [35], panic disorder [36] and PTSD [37], while higher 
basal HRV has been found after successful treatment for depression using psychotherapy 
and anti-depressants [38], [39] and overall physical health [89]. HRV total power increased 
significantly during the main session for the intervention group only, indicating that slow 
paced breathing has a positive impact on HRV. Basal power did not increase from B1 to 
B2 which was unexpected, and would have shown a carry-over effect from slow paced 
breathing. It may take more breathing sessions to show a carry-over effect.  
 
6.3 Respiration and physiology 
 
Skin temperature has been known to increase with an increase in relaxation and decrease 
with an increase with stress as blood moves from the body’s extremities towards major 
organs [17-20]. Peculiarly, the control group’s skin temperature increased from B1 to main 
whereas the intervention group did not, suggesting that the control group relaxed more than 
the intervention group. A possible reason might be that the first session of slow paced 
breathing for the intervention group actually took concentration and induced some level of 
stress [66], [96], [98] and it may take more sessions for the benefits of slow paced breathing 
to show in participants’ physiology. 
Skin conductance is another method shown to reflect stress [14-16] and arousal [12], [13]. 
As stress increases so does moisture on the hands, and with it an increase in skin 
conductance. The control group’s average skin conductance increased significantly from 
main to B2, indicating an increase in stress during B2. A possible reason might be 
participants’ agitation or boredom sitting in the chair for the time period and desire to finish 
the session. It is interesting to note that the increase in stress from Main to B2 was only 
seen in the control group.  It is possible that the breathing exercise for the intervention 
group allowed them to be more relaxed.  
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Skin temperature and skin conductance delta reflects the average of the first 1.5 minutes  
compared to the average of the last 1.5 minutes and indicates an increase or decrease of 
either skin conductance or skin temperature during the main session. There were no 
significant changes for either group. 
 
6.4 Respiration and EEG 
 
There were no significant differences between groups for alpha, theta and beta power 
during B1, M or B2.  However, during B2, both groups saw a decrease in theta power, 
while beta power tended to decrease for the control group only.  
 
The decrease in theta was similar to other research on focused attention abdominal 
breathing [151], [153], however, there were also differences in the results of this study to 
those of previous research efforts [127], [158]. No meaningful conclusions can be drawn 
from the decrease in theta power as similar results were seen for both the control and 
intervention groups. 
 
The Cz EEG probe lies above the primary motor cortex and primary somatosensory cortex, 
with a decrease in beta power from B1 to B2 suggesting that the control group became less 
physically alert over time.   
 
The above small differences in EEG results suggest two possibilities. Either slow paced 
breathing does not impact EEG power, or that one session of slow paced breathing may 
not be enough to cause a significant shift in EEG results to properly evaluate whether slow 
paced breathing impacts EEG power. 
 
6.5 Hypothesis revisited 
 
This section revisits the hypotheses that were tested in this study in terms of whether or not 
the null hypothesis can be accepted or rejected.  A summary of the main reasons for 
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accepting/ rejecting each null hypothesis is also listed.  It should, however, be noted that 
these hypotheses are valid for a single session of slow paced breathing only, and would 
need to be tested against multiple sessions. 
 
H1: Slow paced breathing initiates resonance in the baroreflex system, and therefore 
increases heart rate variability. (Null hypothesis can be rejected) 
- HRV total power increased during the main session for the intervention group but not 
for the control group. 
- HRV total power was significantly higher for the intervention group compared to the 
control group during the main session. 
 
H2: Slow paced breathing increases relaxation and therefore increases efferent vagal flow 
represented by increases high frequency HRV. (The null hypothesis failed to be rejected) 
- No significant differences were found for either group for HRV-HF during any 
session. 
- There was no correlation between respiration frequency and HRV-HF. 
 
H3: Slow paced breathing increases relaxation, which results in less peripheral blood 
vessel constriction and higher peripheral blood flow, and therefore increases finger 
temperature. (The null hypothesis failed to be rejected) 
- No significant difference was found in skin temperature delta for either group during 
the main session. 
- Strangely, the control group (and not the intervention group’s) skin temperature 
increased during the main session, signifying an increase in relaxation. 
 
H4: Slow paced breathing increases relaxation, which diminishes the sweating response, 
and therefore decreases skin conductance. (The null hypothesis failed to be rejected)  
- No significant difference for skin conductance delta for either group during the main 
session. 
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- There was no significant difference for skin conductance for the intervention group, 
however skin conductance increased significantly for the control group during B2, 
signifying an increase in anxiety during B2. 
 
H5: Slow paced breathing increases relaxation and therefore theta and alpha power 
increase, while beta power decreases. (The null hypothesis failed to be rejected) 
- For both groups, theta power tended to decrease during B2, while beta power tended 
to decrease during B2 for the control group only. 
 
6.6 Research limitations and scope for future research 
 
An important limitation to this research is that the impact of only one paced breathing 
session was investigated.  It is possible that EEG results may change significantly if slow 
paced breathing is practised over multiple sessions and/or a longer period of time per 
session.  It is thus suggested that future research efforts should take this into consideration 
in order to test the above hypotheses of paced breathing techniques on EEG and 
physiology.   
 
Another constraint to this study was the small sample size through a limited number of 
participants.  This implies that there may be a greater level of uncertainty in the results 
described in this study making it difficult to distinguish between a real effect and random 
variation, and hence caution must be applied when interpreting the results.  The results in 
this study should therefore be considered as correlational, and not causal.  It is thus 
recommended that future research efforts are to focus on a larger sample size in order to 
strengthen the statistical significance of the project.  
 
There was a high degree of contradiction in the results obtained in this study that may be a 
function of the individual emotional states of participants as well as the small sample size.  
The participants in this research project were students with varying degrees of stress in 
their lives. The majority of these students probably have relatively lower levels of stress, 
in comparison to people in a working environment with greater amounts of responsibility.  
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The impact of slow paced breathing would be easier to quantify on participants with high 
stress levels rather than participants that are already relaxed.  Alternatively, it would be 
interesting to compare groups of stressed and relaxed people. 
 
In addition to the above, the design of the current research was cross-sectional, which 
means that the data were gathered at one specific point in time only.  No pre- and post-
event testing was used, and nor were longitudinal processes evaluated.  Cross-sectional 
studies have an inherent temporal limitation, and in the case of this research, where it is 
possible that the participants emotional and stress states may fluctuate over time or in 
response to external life circumstances, this limitation should be kept in mind. 
 
Women were not included in this study as women have different EEG [197] and 
cortisol [198] responses to stress, and therefore also have different physical responses to 
breathing at different rates.  The results of this study are thus invalid for woman and it is 
recommended that the study be repeated for women and compared to the results of men in 
order to verify previous research [197], [198].   
 
Based on the experience acquired during this project, the following list provides further 
research direction possibilities: 
 Investigating the impact of more than one biofeedback session and/or longer 
experimental sessions on EEG and physiology; 
 As only slow paced breathing was investigated in this study, it would be interesting to 
compare the impacts of different types of breathing on EEG and physiology; 
 Finding and using a participants individual resonant breathing frequency,  
 The use of more EEG probes (and Loreta for determine source localization), MRI or 
PET to determine the location of the brain that is activated by slow paced breathing; 
 Investigation into the impact of breathing and emotional response on BVP amplitude 
and shape [170]; and 
 Investigate the influence of slow paced breathing on different stress levels and in 
different environments. 
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6.7 Conclusion 
 
This project aims to investigate HRV, skin conductance, skin temperature and EEG 
patterns in response to breathing techniques.  Given that stress impacts people’s health and 
performance negatively, this research demonstrated that slow paced breathing strongly 
increases HRV.  Therefore, it is plausible that with more frequent practise, basal HRV 
would increase, and with it benefits such as a reduction in anxiety and increase in 
performance. Slow paced breathing biofeedback shows promise of a simple, cheap, 
measurable and effective method to reduce the impact of stress on physiology.  
 
An interesting idea that came from this research was to evaluate the rhythm and speed of 
the stomach moving in and out during respiration. This was done by finding the percentage 
power in the low frequency band which indicates initial promise as a good indicator for 
HRV. This could be used as an alternative to ECG and BVP with advantages of being 
robust against movement artifact, more robust for people with cold hands (and therefore 
lack of blood flow and poor signal quality), cheap, simple and inconspicuous to wear.  
 
Even though some of the main advantages of WT (such as 3D representation of signals, 
superior computational speed and the ability to better detect small changes in EEG [193] 
than the FFT) were not used in this project, the WT still proved an effective method to 
evaluate EEG signals. 
6.8 Summary 
 
Chapter 6 has presented a discussion and conclusion on the results that are shown in 
Chapter 5.  In summary, slow paced breathing does have an impact on HRV but a limited 
impact on physiology as indicated by no significant changes in skin conductance and 
temperature.  In terms of the effects of paced breathing on EEG, no meaningful significant 
conclusions can be drawn and thus future research possibilities are also discussed to 
address the limitations of this research project. 
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Appendix B: Questionnaires 
_____________________________________________________________________________ 
 
Participant questionnaire PARTICIPANT NUMBER: _____________________ 
 
 
INSTRUCTIONS 1: PLEASE ANSWER THE FOLLOWING QUESTIONS BY CROSSING (x) THE 
RELEVANT BLOCK OR WRITING DOWN YOUR ANSWER IN THE SPACE PROVIDED. 
 
1 Gender 
Male  
Female  
 
2 Age (in complete years) 
  
 
 
INSTRUCTIONS 2: TO WHAT EXTENT DO YOU AGREE WITH EACH OF THE FOLLOWING 
STATEMENTS? PLEASE INDICATE YOUR ANSWER USING THE FOLLOWING 5-POINT SCALE. PLEASE 
ANSWER THE FOLLOWING QUESTIONS BY CROSSING (x) THE RELEVANT BLOCK OR WRITING 
DOWN YOUR ANSWER IN THE SPACE PROVIDED. 
 
1. = never / less than once per month 
2. = twice a month 
3. = once per week 
4. = three times per week 
5. = every day 
 
 
1 I take part in exercise 
 
1 2 3 4 5 
 
 Type of exercise: _____________________________________________________________ 
 
 
2 I take part in breathing exercises 
 
1 2 3 4 5 
 
 
 Type of breathing exercises: ____________________________________________________ 
 
 
  
________________________________________________________________________ 
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3 I take part in meditation practises? 
 
1 2 3 4 5 
 
 
 Type of meditation: ___________________________________________________________ 
 
 
 
INSTRUCTIONS 3: PLEASE PLACE A VERTICAL MARK ON THE LINE BELOW TO INDICATE YOUR 
EXPERIENCE: 
 
1 During the first three minute baseline recording, I felt… 
 
Awake                    Sleepy 
  
 
2 During the twelve minute main recording, I felt… 
 
Awake                    Sleepy 
   
 
 
3 During the last three minute baseline recording, I felt… 
 
Awake                    Sleepy 
   
 
 
4 During the first three minute baseline recording, my mental activity was… 
 
Quiet                     Busy 
  
 
5 During the twelve minute main recording, my mental activity was … 
 
Quiet                     Busy 
   
 
 
6 During the last three minute baseline recording, my mental activity was … 
 
Quiet                     Busy 
   
 
 
INSTRUCTIONS 4: GENERAL FEEDBACK 
  
________________________________________________________________________ 
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Do you have any other comments about your experience eg. Feelings of dizziness / alertness / 
boredom etc? 
 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
____________ 
Do you have any other feedback / comments about this experiment? 
 
______________________________________________________________________________
______________________________________________________________________________
______________________________________________________________________________
____________ 
 
  
  
________________________________________________________________________ 
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